1887

Abstract

Summary

A slide agglutination technique identifying 10 serogroups of (A,B,C,D,F,G,H,I,K and X) has been described previously. In this study, we have used the hamster to compare the ability of the 10 serogroup reference strains to colonise and produce disease. Groups of four hamsters were each given a single intraperitoneal injection of either clindamycin or cefoxitin, and an oral challenge dose of . The time taken to establish faecal colonisation and the length of survival after colonisation were monitored. All hamsters treated with cefoxitin became colonised by day 3 and those challenged with the cytotoxigenic strains of serogroups A,C,H and K developed colitis and died. Among those challenged with the non-toxigenic strains of groups B,D,I and X and the toxigenic strains of groups F and G, faecal colonisation was established without signs of disease. This demonstrates that there are differences in virulence even among toxigenic strains of . The same phenomenon was observed after treatment with clindamycin but the pattern of colonisation was quite different with some strains. In the hamsters challenged with toxigenic strains of groups C and K and non-toxigenic strains of groups D and I, which are highly resistant to clindamycin, the response was the same as with cefoxitin. The results were different with strains which were susceptible to clindamycin. Some animals became colonised much later than those treated with cefoxitin but the mortality was similar. The remaining animals became colonised by day 3, not by the challenge organism but by another strain which always belonged to serogroup D or C; the source of these organisms was thought to be either previously undetected faecal carriage or the environment. Four animals infected by a toxigenic serogroup-C strain died. Another five, colonised by a non-toxigenic serogroup-D strain survived even though they had been challenged with a strain of a virulent serogroup. This protective effect and the differences in the potential to colonise after clindamycin therapy may warrant further investigation in man.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-33-2-85
1990-10-01
2024-12-02
Loading full text...

Full text loading...

/deliver/fulltext/jmm/33/2/medmicro-33-2-85.html?itemId=/content/journal/jmm/10.1099/00222615-33-2-85&mimeType=html&fmt=ahah

References

  1. Delmee M, Homel M, Wauters G. Serogrouping of Clostridium difficile strains by slide agglutination. J Clin Microbiol 1985; 21:323–327
    [Google Scholar]
  2. Delmee M, Laroche Y, Avesani V, Cornelis G. Comparison of serogrouping and polyacrylamide gel electrophoresis for typing Clostridium difficile. J Clin Microbiol 1986; 24:991–994
    [Google Scholar]
  3. Delmee M, Bulliard G, Simon G. Application of a technique for serogrouping Clostridium difficile in an outbreak of antibiotic-associated diarrhoea. J Infect 1986; 13:5–9
    [Google Scholar]
  4. Delmee M, Vandercam B, Avesani V, Michaux JL. Epidemiology and prevention of Clostridium difficile infections in a leukemia unit. Eur J Clin Microbiol 1987; 6:623–627
    [Google Scholar]
  5. Delmee M, Verellen G, Avesani V, Francois G. Clostridium difficile in neonates: serogrouping and epidemiology. EurJPediatr 1988; 147:36–40
    [Google Scholar]
  6. Small JD. Fatal enterocolitis in hamster given lincomycin hydrochloride. Lab Anim Care 1968; 18:411–420
    [Google Scholar]
  7. Bartlett JG, Chang TW, Moon N, Onderdonk AB. Antibiotic-induced lethal enterocolitis in hamsters: studies with eleven agents and evidence to support the pathogenic role of toxin-producing clostridia. Am J Vet Res 1978; 39:1525–1530
    [Google Scholar]
  8. Larson HE, Price AB, Honour P, Borriello SP. Clostridium difficile and the aetiology of pseudmembranous colitis. Lancet 1978; 1:1063–1066
    [Google Scholar]
  9. Lusk RH, Fekety R, Silva J, Browne RA, Ringler DH, Abrams GD. Clindamycin-induced enterocolitis in hamsters. J Infect Dis 1978; 137:464–475
    [Google Scholar]
  10. Boon RJ, Beale AS. Studies with temocillin in hamster model of antibiotic-associated colitis. Antimicrob Agents Chemother 1985; 27:980–981
    [Google Scholar]
  11. Rolfe RD, Iaconis JP. Intestinal colonization of infant hamsters with Clostridium difficile. Infect Immun 1983; 42:480–486
    [Google Scholar]
  12. Weinberg DS, Fernandes PB, Kao CC, Clark JM, Bonner DP, Sykes RB. Evaluation of aztreonam, cefoperazone, latamoxef and ceftazidime in the hamster colitis model. J Antimicrob Chemother 1986; 18:729–745
    [Google Scholar]
  13. George WL, Sutter VL, Citron D, Finegold SM. Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol 1979; 9:214–219
    [Google Scholar]
  14. Sutter VL, Barry AL, Wilkins TD, Zabransky RJ. Collabo rative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother 1979; 16:495–502
    [Google Scholar]
  15. Donta ST, Meyers MG. Clostridium difficile toxin in asymptomatic neonates. J Pediatr 1982; 100:431–434
    [Google Scholar]
  16. Mardh P-A, Helin I, Colleen I, Oberg M, Holst E. Clostridium difficile toxin in faecal specimens of healthy children and children with diarrhoea. Acta Paediatr Scand 1982; 71:275–278
    [Google Scholar]
  17. Rietra PJGM, Slaterus KW, Zanen HC, Meuwissen SGM. Clostridial toxin in faeces of healthy infants. Lancet 1978; 2:319
    [Google Scholar]
  18. Adler SP, Chandrika T, Berman WF. Clostridium difficile associated with pseudomembranous colitis. Occurrence in a 12-week-old infant without prior antibiotic therapy. Am J Dis Child 1981; 135:820–822
    [Google Scholar]
  19. Mandal BK, Watson B, Ellis M. Pseudomembranous colitis in a 5-week-old infant. Br Med J 1982; 284:345–346
    [Google Scholar]
  20. Borriello SP, Ketley JM, Mitchell TJ et al. Clostridium difficile—a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis. J Med Microbiol 1987; 24:53–64
    [Google Scholar]
  21. Lyerly DM, Saum KE, MacDonald DK, Wilkins TD. Effects of Clostridium difficile toxins given intragastri- cally to animals. Infect Immun 1985; 47:349–352
    [Google Scholar]
  22. Libby JM, Donta ST, Wilkins TD. Clostridium difficile toxin A in infants. J Infect Dis 1983; 148:606
    [Google Scholar]
  23. Ebright JR, Fekety R, Silva J, Wilson KH. Evaluation of eight cephalosporins in hamster colitis model. Antimicrob Agents Chemother 1981; 19:980–986
    [Google Scholar]
  24. Toshniwal R, Silva J, Fekety R, Kim KH. Studies on the epidemiology of colitis due to Clostridium difficile in hamsters. J Infect Dis 1981; 143:51–54
    [Google Scholar]
  25. Ensminger PW, Counter FT, Thomas LJ, Lubbehusen PP. Susceptibility, resistance development, and synergy of antimicrobial combinations against Clostridium difficile. Curr Microbiol 1982; 7:59–62
    [Google Scholar]
  26. Nakamura S, Nakashio S, Mikawa M, Yamakawa K, Okumura S, Nishida S. Antimicrobial susceptibility of Clostridium difficile from different sources. Microbiol Immunol 1982; 26:25–30
    [Google Scholar]
  27. Delmee M, Avesani V. Correlation between serogroup and susceptibility to chloramphenicol, clindamycin, erythromycin, rifampicin and tetracycline among 308 isolates of Clostridium difficile. J Antimicrob Chemother 1988; 22:325–331
    [Google Scholar]
  28. Wilson KH, Sheagren JN. Antagonism of toxigenic Clostridium difficile by nontoxigenic C. difficile. J Infect Dis 1983; 147:733–736
    [Google Scholar]
  29. Borriello SP, Barclay FE. Protection of hamsters against Clostridium difficile ileocaecitis by prior colonisation with non-pathogenic strains. J Med Microbiol 1985; 19:339–350
    [Google Scholar]
/content/journal/jmm/10.1099/00222615-33-2-85
Loading
/content/journal/jmm/10.1099/00222615-33-2-85
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error